Paul Hudson, CEO of Sanofi, discussed the benefits of using AI for decision-making in medicine at Davos. AI's impartiality and lack of attachment to projects or careers can provide valuable insights, aiding in drug development processes.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing